Literature DB >> 4564677

In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans.

T G Mitchell, L Friedman.   

Abstract

Five isolates of Cryptococcus neoformans type A with stable capsular thicknesses were used. Three of the isolates had capsules of medium size, one had a minimal capsule, and the other, a large capsule. Peritoneal exudate cells from Lewis rats were cultured on cover slips in Leighton tubes containing medium 199 and 20% fresh, isologous normal rat serum. Yeast cells were added to the Leighton tube cultures, and, 2 hr later, the extracellular yeasts were rinsed out. Cover slips were removed from some tubes for Wright staining and measurement of both phagocytosis and loss of macrophages. The remaining tubes were reincubated and sampled at 24 or 48 hr. To determine fate of yeast cells after ingestion, washed cover slips were inverted onto agar slide cultures, and specific macrophages were observed in situ for subsequent multiplication of their intracellular yeasts. More than half of the macrophages survived 24 to 48 hr of exposure to different strains of C. neoformans, with small, medium, or large capsules. Phagocytic activity was dependent upon a heat-labile factor in normal rat serum. The number of yeast ingested by macrophages was inversely proportional to the capsular size. Although most of the ingested yeasts were resistant to intracellular killing, the agar culture technique clearly demonstrated that many were unable to multiply, presumably dead. Three of the isolates were more susceptible than the other two, and the fate of these yeasts after engulfment was not correlated with their capsular size.

Entities:  

Mesh:

Year:  1972        PMID: 4564677      PMCID: PMC422397          DOI: 10.1128/iai.5.4.491-498.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  16 in total

1.  Passively-acquired immunity in experimental cryptococcosis.

Authors:  D B Louria; T Kaminski
Journal:  Sabouraudia       Date:  1965-06

Review 2.  Cryptococcosis: current status.

Authors:  M L Littman; J E Walter
Journal:  Am J Med       Date:  1968-12       Impact factor: 4.965

3.  Granuloma formation in cryptococcosis.

Authors:  A Shahar; Y Kletter; M Aronson
Journal:  Isr J Med Sci       Date:  1969 Nov-Dec

4.  Experimental murine cryptococcosis: effect of hyperimmunization to capsular polysaccharide.

Authors:  M B Goren
Journal:  J Immunol       Date:  1967-05       Impact factor: 5.422

5.  Resistance against Cryptococcus conferred by intracellular bacteria and protozoa.

Authors:  L O Gentry; J S Remington
Journal:  J Infect Dis       Date:  1971-01       Impact factor: 5.226

6.  Serologic tests in diagnosis and prognosis of cryptococcosis.

Authors:  M A Gordon; D K Vedder
Journal:  JAMA       Date:  1966-09-19       Impact factor: 56.272

7.  Formation of histiocyte rings in response to Cryptococcus neoformans infection.

Authors:  S Schneerson-Porat; A Shahar; M Aronson
Journal:  J Reticuloendothel Soc       Date:  1965-09

8.  Cryptococcus neoformans. 3. Inhibition of phagocytosis.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1968-01       Impact factor: 3.490

9.  Cryptococcus neoformans. II. Phagocytosis by human leukocytes.

Authors:  G S Bulmer; M D Sans
Journal:  J Bacteriol       Date:  1967-11       Impact factor: 3.490

10.  Medium-dependent activity of immune serum on Brucella-infected macrophages.

Authors:  D J Ralston; S S Elberg
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

View more
  62 in total

1.  Radial mass density, charge, and epitope distribution in the Cryptococcus neoformans capsule.

Authors:  Michelle E Maxson; Ekaterina Dadachova; Arturo Casadevall; Oscar Zaragoza
Journal:  Eukaryot Cell       Date:  2006-11-17

Review 2.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

3.  Resistance to challenge and macrophage activity in mice previously vaccinated with formalin-killed Cryptococcus neoformans.

Authors:  D M Anderson; M A Dykstra
Journal:  Mycopathologia       Date:  1984-06-30       Impact factor: 2.574

4.  Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection.

Authors:  L K Cauley; J W Murphy
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

5.  Histopathological studies on experimental cryptococcosis in nude mice.

Authors:  K Nishimura; M Miyaji
Journal:  Mycopathologia       Date:  1979-09-28       Impact factor: 2.574

6.  Host defense in Cryptococcosis. III. In vivo alteration of immunity.

Authors:  J R Graybill; L Mitchell
Journal:  Mycopathologia       Date:  1979-12-28       Impact factor: 2.574

7.  Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide.

Authors:  T R Kozel
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

8.  Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells.

Authors:  S Schelenz; R Malhotra; R B Sim; U Holmskov; G J Bancroft
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Cryptococcus neoformans: in vivo protection of mice by pretreatment with pyran copolymer.

Authors:  R A Fromtling; H J Shadomy; A M Kaplan
Journal:  Mycopathologia       Date:  1984-03-15       Impact factor: 2.574

10.  Intravascular granuloma induced by intravenous inoculation of Cryptococcus neoformans.

Authors:  H Yamaoka; N Sakaguchi; K Sano; M Ito
Journal:  Mycopathologia       Date:  1996       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.